Cargando…

Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome

OBJECTIVES: According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Qianqian, Zheng, Jianhua, Cao, Yijuan, Yan, Xiaonan, Zhang, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387166/
https://www.ncbi.nlm.nih.gov/pubmed/34457001
http://dx.doi.org/10.1155/2021/7172388
_version_ 1783742403309469696
author Yin, Qianqian
Zheng, Jianhua
Cao, Yijuan
Yan, Xiaonan
Zhang, Hong
author_facet Yin, Qianqian
Zheng, Jianhua
Cao, Yijuan
Yan, Xiaonan
Zhang, Hong
author_sort Yin, Qianqian
collection PubMed
description OBJECTIVES: According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatment of individuals with MS and pre-MS are imperative to prevent their adverse consequences. Moreover, fasting plasma glucose (FPG) was not accurate in detecting pathoglycemia in women with PCOS as they have shown characteristically postprandial abnormalities in the carbohydrate metabolism. Therefore, we aimed to compare the discriminative performance of various indices for identifying MS and pre-MS/MS (pre-MS and MS) using the updated Chinese Diabetes Society (uCDS) criteria in Chinese women with PCOS. METHODS: 1083 Chinese women with PCOS were included in this study. We measured and evaluated 8 indices in all individuals. Based on the uCDS criteria for MS, patients who had no less than two components of MS but did not meet the criteria for the diagnosis of MS were considered as having pre-MS. Receiver operating characteristic (ROC) curves and the area under ROC curves (AUCs) levels were used to assess the accuracy of each index in detecting MS and pre-MS/MS. RESULTS: Among the 8 indices assessed, the lipid accumulation product (LAP) provided the highest AUCs for detecting MS and pre-MS/MS, followed by CVAI, WTI, VAI, TyG, TG/HDL, WC, and BMI. The optimal cutoff points determined for LAP were 45.13 (sensitivity 88.0%, specificity 88.4%, and Youden index 0.764) for MS and 28.01 (sensitivity 87.5%, specificity 80.7%, and Youden index 0.681) for pre-MS/MS, respectively. CONCLUSIONS: uCDS criteria are reasonably more suitable for detecting MS and pre-MS in Chinese women with PCOS. Based on this criterion, LAP is the best index for the diagnosis of MS and pre-MS/MS in Chinese women with PCOS, out of the 8 obesity and lipid-related indices assessed.
format Online
Article
Text
id pubmed-8387166
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-83871662021-08-26 Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome Yin, Qianqian Zheng, Jianhua Cao, Yijuan Yan, Xiaonan Zhang, Hong Int J Endocrinol Research Article OBJECTIVES: According to the International Diabetes Federation (IDF) criteria, previous studies in Chinese women with polycystic ovary syndrome (PCOS) reported a low prevalence of metabolic syndrome (MS); however, the same population predisposed to developing pre-MS. Early identification and treatment of individuals with MS and pre-MS are imperative to prevent their adverse consequences. Moreover, fasting plasma glucose (FPG) was not accurate in detecting pathoglycemia in women with PCOS as they have shown characteristically postprandial abnormalities in the carbohydrate metabolism. Therefore, we aimed to compare the discriminative performance of various indices for identifying MS and pre-MS/MS (pre-MS and MS) using the updated Chinese Diabetes Society (uCDS) criteria in Chinese women with PCOS. METHODS: 1083 Chinese women with PCOS were included in this study. We measured and evaluated 8 indices in all individuals. Based on the uCDS criteria for MS, patients who had no less than two components of MS but did not meet the criteria for the diagnosis of MS were considered as having pre-MS. Receiver operating characteristic (ROC) curves and the area under ROC curves (AUCs) levels were used to assess the accuracy of each index in detecting MS and pre-MS/MS. RESULTS: Among the 8 indices assessed, the lipid accumulation product (LAP) provided the highest AUCs for detecting MS and pre-MS/MS, followed by CVAI, WTI, VAI, TyG, TG/HDL, WC, and BMI. The optimal cutoff points determined for LAP were 45.13 (sensitivity 88.0%, specificity 88.4%, and Youden index 0.764) for MS and 28.01 (sensitivity 87.5%, specificity 80.7%, and Youden index 0.681) for pre-MS/MS, respectively. CONCLUSIONS: uCDS criteria are reasonably more suitable for detecting MS and pre-MS in Chinese women with PCOS. Based on this criterion, LAP is the best index for the diagnosis of MS and pre-MS/MS in Chinese women with PCOS, out of the 8 obesity and lipid-related indices assessed. Hindawi 2021-08-17 /pmc/articles/PMC8387166/ /pubmed/34457001 http://dx.doi.org/10.1155/2021/7172388 Text en Copyright © 2021 Qianqian Yin et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Yin, Qianqian
Zheng, Jianhua
Cao, Yijuan
Yan, Xiaonan
Zhang, Hong
Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_full Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_fullStr Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_full_unstemmed Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_short Evaluation of Novel Obesity and Lipid-Related Indices as Indicators for the Diagnosis of Metabolic Syndrome and Premetabolic Syndrome in Chinese Women with Polycystic Ovary Syndrome
title_sort evaluation of novel obesity and lipid-related indices as indicators for the diagnosis of metabolic syndrome and premetabolic syndrome in chinese women with polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387166/
https://www.ncbi.nlm.nih.gov/pubmed/34457001
http://dx.doi.org/10.1155/2021/7172388
work_keys_str_mv AT yinqianqian evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT zhengjianhua evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT caoyijuan evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT yanxiaonan evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome
AT zhanghong evaluationofnovelobesityandlipidrelatedindicesasindicatorsforthediagnosisofmetabolicsyndromeandpremetabolicsyndromeinchinesewomenwithpolycysticovarysyndrome